ArticlePharmaceuticals (Basel, Switzerland)2022

Construction and Validation of an Oxaliplatin-Resistant Gene Signature in Colorectal Cancer Patients Who Underwent Chemotherapy.

Yixin Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.